ethambutol has been researched along with Body Weight in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (62.86) | 18.7374 |
1990's | 3 (8.57) | 18.2507 |
2000's | 4 (11.43) | 29.6817 |
2010's | 5 (14.29) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Aarnoutse, RE; Adhiarta, IG; Alisjahbana, B; Kariadi, SH; Nijland, HM; Ruslami, R; van Crevel, R | 1 |
Äbelö, A; Ashton, M; Bienvenu, E; Birgersson, S; Sundell, J | 1 |
Boukary, I; Daouda, M; Hanki, Y; Harouna, SH; Morou, S; Piubello, A; Souleymane, MB; Van Deun, A | 1 |
Bhatnagar, S; Faurholt-Jepsen, D; Friis, H; Grewal, HM; Kabra, SK; Lodha, R; Mukherjee, A; Saini, S; Singh, S; Singh, V | 1 |
Chirehwa, MT; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, P; Rustomjee, R; Smith, P | 1 |
Gie, RP; Graham, SM; Grzemska, M | 1 |
Alffenaar, JW; Hasenbosch, RE; Koopmans, SA; Kosterink, JG; van Altena, R; van der Werf, TS | 1 |
Adhvaryu, MR; Reddy, N; Vakharia, BC | 1 |
Chandrasekaran, V; Gurumurthy, P; Immanuel, C; Prabhakar, R; Ramachandran, G; Venkatesan, P | 1 |
Gausi, F; Harries, AD; Salaniponi, FM | 1 |
Anglaret, X; Lacassin, F; Leport, C; Longuet, P; Perronne, C; Saba, J; Vildé, JL | 1 |
Belt, EL; Durrheim, DN | 1 |
Aral, Y; Cakir, B; Demirbaş, B; Güler, S; Gürsoy, G; Odabaşi, E; Yönem, A | 1 |
Göbel, D; Jungbluth, H; Kropp, R; Matthiessen, W; Radenbach, KL; Wundschock, M | 1 |
King, AB; Schwartz, R | 1 |
Pyle, MM | 1 |
Suzuki, T | 1 |
Benkert, K; Blaha, H; Petersen, KF; Schmid, PC | 1 |
Aoyagi, T; Gomi, J | 1 |
Guerra Sanz, FJ | 1 |
Ashba, JK; Boyce, JM | 1 |
Orou, F; Schabel, F; Sideroff, G | 1 |
Kraan, JK; Mulder, RJ; van Dijk, B | 1 |
Dume, T; Wagner, C; Wetzels, E | 1 |
Dormer, BA; Salinger, PL | 1 |
Hussels, H; Otto, HS | 1 |
Hetrick, C; Ras, R; Turri, M | 1 |
Raab, WP | 1 |
Devulder, B; Martin, JC; Tacquet, A; Tison, F | 1 |
Orlowski, EH | 1 |
Ilgner, M; Kollmeier, H; Voss, H; Winkler, E | 1 |
Daddi, G; Lucchesi, M; Mancini, P | 1 |
Lucchesi, M; Mancini, P; Matzeu, M | 1 |
Fandos, E; Guallar, J | 1 |
1 review(s) available for ethambutol and Body Weight
Article | Year |
---|---|
Ethambutol and viomycin.
Topics: Adolescent; Aged; Body Weight; Child, Preschool; Cycloserine; Deafness; Ethambutol; Female; Humans; Isoniazid; Kidney Diseases; Male; Mycobacterium bovis; Mycobacterium Infections; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Pulmonary; Viomycin; Vision Disorders; Visual Acuity | 1970 |
7 trial(s) available for ethambutol and Body Weight
Article | Year |
---|---|
Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial.
Topics: Adolescent; Antitubercular Agents; Body Height; Body Mass Index; Body Weight; Child; Child, Preschool; Dietary Supplements; Double-Blind Method; Ethambutol; Female; Humans; India; Infant; Isoniazid; Male; Micronutrients; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Zinc | 2014 |
Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach.
Topics: Adult; Antitubercular Agents; Blood Sedimentation; Body Weight; Chemical and Drug Induced Liver Injury; Curcuma; Drug Therapy, Combination; Ethambutol; Female; Hemoglobins; Humans; Isoniazid; Liver Diseases; Male; Middle Aged; Patient Compliance; Plant Preparations; Pyrazinamide; Rifampin; Tinospora; Treatment Outcome; Tuberculosis | 2008 |
[A pilot and a controlled study of the influence of ethambutol on serum urate concentration and uric acid clearance (author's transl)].
Topics: Alcoholism; Body Weight; Creatinine; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Uric Acid | 1979 |
A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months.
Topics: Antibody Formation; Body Weight; Clinical Trials as Topic; Cycloserine; Drug Combinations; Drug Resistance; Ethambutol; Ethionamide; Fever; Follow-Up Studies; Humans; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1975 |
Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
Topics: Body Weight; Clinical Trials as Topic; Drug Synergism; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1969 |
Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Body Weight; Ethambutol; Ethionamide; Female; Hemoglobins; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1972 |
[Combined rifampicin-ethambutol therapy of resistent pulmonary tuberculosis. Effectiveness of various rifampicin doses in combination with ethambutol].
Topics: Adult; Body Weight; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1970 |
27 other study(ies) available for ethambutol and Body Weight
Article | Year |
---|---|
Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes.
Topics: Adult; Antitubercular Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedule; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2010 |
Population Pharmacokinetics and Pharmacogenetics of Ethambutol in Adult Patients Coinfected with Tuberculosis and HIV.
Topics: Administration, Oral; Adult; Antitubercular Agents; Biological Availability; Body Weight; Coinfection; Cytochrome P-450 CYP1A2; Ethambutol; Female; Genotype; HIV Infections; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Rwanda; Tuberculosis, Pulmonary | 2020 |
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.
Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Clofazimine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Niger; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Biotransformation; Body Weight; Clinical Trials as Topic; Cohort Studies; Coinfection; Computer Simulation; Ethambutol; Female; Half-Life; HIV Infections; Humans; Isoniazid; Liver; Male; Middle Aged; Models, Statistical; Rifampin; Tuberculosis, Pulmonary | 2016 |
The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
Topics: Antitubercular Agents; Body Weight; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis; World Health Organization | 2015 |
Ethambutol-induced optical neuropathy: risk of overdosing in obese subjects.
Topics: Adult; Aged; Antitubercular Agents; Body Weight; Drug Overdose; Ethambutol; Female; Humans; Male; Middle Aged; Obesity; Optic Nerve Diseases; Retrospective Studies | 2008 |
Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Area Under Curve; Body Weight; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Staphylococcus aureus; Time Factors | 2003 |
Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
Topics: Administration, Oral; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Weight; Communicable Disease Control; Drug Therapy, Combination; Drug Utilization Review; Ethambutol; Female; Guideline Adherence; Hospital Records; Hospitals, Public; Humans; Isoniazid; Malawi; Male; Middle Aged; Pyrazinamide; Registries; Rifampin; Tuberculosis, Pulmonary | 2004 |
Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fever; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 1994 |
Tuberculosis control programme guidelines--treatment regimens.
Topics: Antitubercular Agents; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Optic Neuritis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; South Africa; Streptomycin; Tuberculosis | 1996 |
Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Mass Index; Body Weight; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leptin; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 1999 |
Effects of the antituberculous drug ethambutol on zinc absorption, turnover and distribution in rats fed diet marginal and adequate in zinc.
Topics: Animals; Body Weight; Diet; Eating; Ethambutol; Intestinal Absorption; Male; Rats; Rats, Inbred Strains; Statistics as Topic; Tissue Distribution; Zinc; Zinc Radioisotopes | 1987 |
[Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antitubercular Agents; Body Weight; Ethambutol; Ethionamide; Injections, Intramuscular; Kanamycin; Lung; Mice; Organ Size; Pyrazinamide; Rifampin; Spleen; Tuberculosis; Viomycin | 1971 |
[Plasma-levels of ethambutol in children (author's transl)].
Topics: Adolescent; Age Factors; Body Weight; Child; Child, Preschool; Circadian Rhythm; Ethambutol; Female; Humans; Male; Tuberculosis, Pulmonary | 1974 |
Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
Topics: Adult; Body Weight; Drug Therapy, Combination; Ethambutol; Exanthema; Female; Fever; Follow-Up Studies; Gastrointestinal Diseases; Hemorrhage; Humans; Male; Middle Aged; Pain; Pyrazinamide; Recurrence; Rifampin; Shock; Sputum; Time Factors; Tuberculosis, Pulmonary | 1973 |
Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
Topics: Body Weight; Drug Therapy, Combination; Ethambutol; Female; Fever; Headache; Humans; Male; Nausea; Pain; Purpura, Thrombocytopenic; Rifampin; Time Factors; Tuberculosis, Pulmonary; Vomiting | 1973 |
Undiagnosed tuberculosis in a general hospital.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Biopsy; Body Weight; Bone Marrow; Ethambutol; Fatigue; Female; Hospitals, General; Humans; Isoniazid; Liver; Male; Middle Aged; Mycobacterium tuberculosis; Radiography; Spleen; Tuberculosis; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1972 |
[Studies on the occurrence of optic nerve diseases in the course of myambutol therapy].
Topics: Adolescent; Adult; Aged; Body Weight; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Male; Middle Aged; Optic Atrophy; Optic Neuritis; Tuberculosis, Pulmonary | 1972 |
[Pharmacokinetics of ethambutol in healthy individuals and in patients with terminal renal failure].
Topics: Body Weight; Ethambutol; Feces; Humans; Kidney Failure, Chronic; Mycobacterium tuberculosis; Nephrectomy; Peritoneal Dialysis; Renal Dialysis; Time Factors | 1971 |
[Serum ethambutol concentration in childhood].
Topics: Adolescent; Age Factors; Body Surface Area; Body Weight; Child; Child, Preschool; Ethambutol; Humans; Tuberculosis, Pulmonary | 1971 |
Renal effects of antituberculous antibiotics.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Antitubercular Agents; Body Weight; Ethambutol; Female; Injections, Intraperitoneal; Kanamycin; Kidney; L-Lactate Dehydrogenase; Leucyl Aminopeptidase; Male; Rats; Rifampin; Streptomycin | 1970 |
[Activity of Isoxyl on Mycobacterium kansasii; studies in vitro and in the pneumoconiotic guinea pig].
Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Ethambutol; Ethionamide; Guinea Pigs; Isoniazid; Lung; Mycobacterium; Mycobacterium Infections; Phenylthiourea; Pneumoconiosis; Radiography; Time Factors; Tuberculosis, Pulmonary | 1970 |
[Standard therapy of tuberculosis].
Topics: Antitubercular Agents; Body Weight; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1971 |
[Silicotuberculosis and ethambutol treatment].
Topics: Aged; Alkaline Phosphatase; Antitubercular Agents; Blood Proteins; Body Weight; Drug Resistance, Microbial; Ethambutol; Humans; Injections, Intramuscular; Isoniazid; Middle Aged; Silicotuberculosis; Sputum; Streptomycin; Transaminases; Vision Disorders | 1968 |
[Intermittent rifomycin therapy of experimental tuberculosis in guinea pigs].
Topics: Animals; Body Weight; Drug Synergism; Ethambutol; Guinea Pigs; Isoniazid; Rifampin; Tuberculosis | 1968 |
[Intermittent ethambutol therapy of experimental tuberculosis in guinea pigs].
Topics: Animals; Body Weight; Drug Synergism; Ethambutol; Guinea Pigs; Isoniazid; Tuberculosis | 1968 |
[Results on the use of ethambutol in the treatment of chronic pulmonary tuberculosis in a sanatorial environment].
Topics: Adult; Blood Sedimentation; Body Weight; Ethambutol; Female; Humans; Male; Middle Aged; Radiography; Tuberculosis, Pulmonary; Vision Disorders | 1968 |